YOLFTbeta
TG Therapeutics Inc

TG Therapeutics Inc

TGTX · NASDAQ · Healthcare / Biotechnology

56USD+1.63 (+3.00%)

Price History

Full chart

Market Stats

Previous Close54.37
Open55.12
Day Range54.76 – 56.83
52-Week Range26.76 – 59.3
Volume1.81M
Market Cap8.79B
P/E (TTM)20.96
Forward P/E25.91
EPS2.74
Dividend Yield0.00%
Beta1.66
50-Day Avg53.56
200-Day Avg40.58

About

TG Therapeutics, Inc., a commercial stage biopharmaceutical company, focuses on the acquisition, development, and commercialization of novel treatments for B-cell mediated diseases in the United States and internationally. The company provides BRIUMVI, an anti-CD20 monoclonal antibody for the treatment of adult patients with relapsing forms of multiple sclerosis (RMS), including clinically isolated syndrome, relapsing-remitting disease, and active secondary progressive disease in adults. The company's development pipeline comprises Ublituximab IV, glycoengineered anti-CD20 mAb for the treatment of relapsing MS; TG-1701 is an orally available and covalently bound Bruton's tyrosine kinase (BTK) inhibitor that exhibits selectivity to BTK in vitro kinase screening; and TG-1801, a bispecific CD47 and CD19 antibody. Its research pipeline includes various investigational medicines. The company has license agreements with LFB Biotechnologies S.A.S; GTC Biotherapeutics; LFB/GTC LLC; Ildong Pharmaceutical Co. Ltd.; and Jiangsu Hengrui Medicine Co. The company was incorporated in 1993 and is based in Morrisville, North Carolina.

Company Details

  • SectorHealthcare
  • IndustryBiotechnology
  • CEOMr. Michael S. Weiss Esq., J.D.
  • Employees399
  • Headquarters3020 Carrington Mill Blvd., Morrisville, NC, United States, 27560, USA
  • Websitehttps://www.tgtherapeutics.com

Leadership

  • Mr. Michael S. Weiss Esq., J.D.Chairman, CEO & President · b. 1966
  • Mr. Sean A. Power CPACFO, Corporate Secretary & Treasurer · b. 1982
  • Ms. Jenna BoscoSenior Vice President of Corporate Communications
  • Mr. Adam WaldmanChief Commercialization Officer

Financials

Income Statement

Line item1996-12-311997-12-311998-12-311999-12-312000-12-312001-12-312002-12-312003-12-312004-12-312005-12-312006-12-312007-12-312008-12-312009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Revenue100.00K100.00K3.00M1.20M5.36M2.71M500.00K--------019.05K152.38K152.38K152.38K152.38K152.38K152.00K152.00K152.00K6.69M2.79M233.66M329.00M616.29M
Cost of Revenue--100.00K-200.00K800.00K4.06M2.08M---------0020.32M55.87M63.32M79.06M118.78M88.00K282.00K374.00K790.00K265.00K14.13M38.49M100.71M
Gross Profit100.00K200.00K3.20M400.00K1.30M629.35K500.00K--------019.05K152.38K152.38K152.38K152.38K152.38K64.00K152.00K152.00K5.90M2.52M219.53M290.52M515.57M
Operating Income-3.80M-5.30M-2.70M-2.70M-3.16M-3.11M-1.55M-4.76M-6.14M-19.36M-10.00M-12.14M-4.41M-1.77M-2.02M-881.97K-26.90M-22.97M-55.72M-63.18M-78.97M-118.71M-174.40M-169.06M-273.59M-344.77M-218.32M20.63M41.93M123.32M
EBITDA-3.70M-5.20M-3.00M-2.60M-3.09M-3.04M-995.46K-2.11M-5.87M-19.09M-9.63M-11.98M-3.93M-1.74M1.90M-845.98K-24.95M-19.52M-55.72M-63.16M-78.91M-118.63M-173.39M-167.30M-272.68M-341.97M-213.11M26.10M49.90M134.36M
Net Income-3.60M-5.20M-2.80M-2.40M-5.80M-1.73M-1.55M-5.96M-5.90M-19.14M-9.70M-12.03M-4.27M-2.79M623.64K-853.07K-18.07M-20.48M-55.78M-62.95M-78.25M-118.48M-173.48M-172.87M-279.38M-348.10M-223.81M12.67M23.38M447.18M
R&D1.10M2.60M3.00M1.10M1.13M886.72K539.75K1.72M4.15M17.07M6.17M8.54M1.80M40.38K495.79K327.28K20.57M12.62M31.35M43.45M66.49M96.89M153.79M154.18M165.90M222.58M125.35M76.19M94.29M160.22M
Interest Expense00000000001.67K47664.79K548.36K1.27M7.10K905.74K952.89K930.70K972.74K01.14M1.73M5.29M6.33M5.64M10.19M12.62M24.03M26.73M

Balance Sheet

Line item1996-12-311997-12-311998-12-311999-12-312000-12-312001-12-312002-12-312003-12-312004-12-312005-12-312006-12-312007-12-312008-12-312009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Assets2.40M8.80M6.50M4.00M3.18M1.76M250.74K7.80M5.65M11.21M3.45M980.58K1.25M365.66K18.64M15.91M22.07M48.11M86.75M113.47M54.78M97.38M83.62M163.01M625.64M379.63M193.57M329.59M577.69M1.06B
Total Liabilities300.00K400.00K600.00K600.00K2.08M508.61K577.73K966.02K1.20M1.67M1.94M1.87M5.62M7.15M24.00M6.27M6.52M48.11M86.75M113.47M54.78M97.38M59.58M124.40M106.29M142.48M134.99M169.09M355.33M415.23M
Total Equity2.10M8.40M5.90M3.40M496.06K1.25M-326.99K6.83M4.45M9.54M1.50M-891.09K-4.38M-6.78M-5.36M9.62M15.55M40.05M80.10M101.57M35.87M66.99M24.04M38.62M519.35M237.15M58.59M160.50M222.36M648.02M
Cash2.30M8.50M5.80M3.50M2.66M1.59M116.29K7.41M905.66K9.83M3.03M649.69K106.02K18.00K478.67K9.75M16.46M40.49M55.71M55.06M25.03M56.72M41.96M112.64M553.44M298.89M102.30M92.93M179.89M79.15M
Total Debt------800.00K-----1.26M1.94M18.81M4.88M3.16M742.31K275.19K211.55K68.88K127.61K67.00K40.80M41.98M79.05M83.06M110.80M253.72M260.73M
Net Debt-2.30M-8.50M-5.80M-3.50M-2.66M-1.59M683.71K-7.41M-905.66K-9.83M-3.03M-649.69K1.15M1.93M18.33M-4.86M-13.30M-39.74M-55.44M-54.85M-24.96M-56.59M-41.89M-71.83M-511.46M-219.84M-19.24M17.86M73.83M181.58M

Cash Flow

Line item1996-12-311997-12-311998-12-311999-12-312000-12-312001-12-312002-12-312003-12-312004-12-312005-12-312006-12-312007-12-312008-12-312009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Operating Cash Flow-4.00M-4.10M-2.60M-2.30M-1.15M-4.47M-1.43M-3.45M-5.69M-6.24M-7.75M-10.23M-4.44M-1.05M-1.97M-86.58K-5.19M-10.82M-35.06M-44.69M-61.59M-93.76M-128.93M-132.81M-214.51M-295.63M-176.17M-31.41M-40.52M-24.77M
Investing Cash Flow-100.00K-200.00K-200.00K-100.00K-317.97K2.89M-5.46K160.64K-4.21M3.47M968.78K-9.13K-8.97K-516.52K10.39K-1.40K-4.93M-18.36M-24.69M26.55M-8.21M1.18M-718.00K-24.51M-332.00K-20.01M-50.65M-1.04M13.80M
Financing Cash Flow1.30M10.60M100.00K-661.28K510.79K-37.44K8.98M3.39M11.70M-15.26K7.86M3.91M961.77K1.91M9.82M11.90M39.78M68.64M68.72M5.02M133.66M113.64M204.21M679.83M41.42M-391.00K72.70M128.53M-89.73M
Capital Expenditure100.00K200.00K200.00K100.00K171.35K108.25K5.46K6.55K138.34K39.55K37.05K9.13K8.97K02.84K01.40K5.68K18.57K42.22K343.99K2.23K90.00K131.00K357.00K401.00K14.00K045.00K214.00K
Free Cash Flow-4.10M-4.30M-2.80M-2.40M-1.32M-4.58M-1.44M-3.46M-5.83M-6.28M-7.79M-10.24M-4.45M-1.05M-1.97M-86.58K-5.19M-10.83M-35.08M-44.73M-61.94M-93.77M-129.01M-132.94M-214.86M-296.04M-176.18M-31.41M-40.56M-24.99M
Dividends Paid-----987807--1.30K-----0000000-000----

Earnings

Report DateMar 31, 1998Jun 30, 1998Sep 30, 1998Dec 31, 1998Mar 31, 1999Jun 30, 1999Sep 30, 1999Dec 31, 1999Mar 31, 2000Jun 30, 2000Sep 30, 2000Dec 31, 2000Mar 31, 2001Jun 30, 2001Sep 30, 2001Dec 31, 2001Mar 31, 2002Jun 30, 2002Sep 30, 2002Dec 31, 2002Mar 31, 2003Jun 30, 2003Sep 30, 2003Dec 31, 2003Mar 31, 2004Jun 30, 2004Sep 30, 2004Dec 31, 2004Mar 31, 2005Jun 30, 2005Sep 30, 2005May 15, 2006Aug 14, 2006Nov 14, 2006May 15, 2007Aug 14, 2007Nov 14, 2007May 20, 2008Aug 19, 2008Dec 3, 2008Feb 25, 2009May 19, 2009Aug 14, 2009Nov 16, 2009Mar 3, 2010May 24, 2010Aug 16, 2010Nov 15, 2010Mar 2, 2011May 23, 2011Aug 15, 2011Nov 14, 2011May 21, 2012Aug 9, 2012Nov 8, 2012Mar 12, 2013May 13, 2013Aug 1, 2013Nov 11, 2013Mar 5, 2014May 12, 2014Jul 21, 2014Nov 10, 2014Mar 11, 2015May 4, 2015Aug 10, 2015Nov 9, 2015Mar 7, 2016May 10, 2016Aug 8, 2016Nov 7, 2016Mar 10, 2017May 5, 2017Aug 9, 2017Nov 8, 2017Mar 8, 2018May 8, 2018Aug 7, 2018Nov 9, 2018Mar 1, 2019May 10, 2019Aug 9, 2019Nov 12, 2019Mar 2, 2020May 11, 2020Aug 10, 2020Nov 9, 2020Mar 1, 2021May 10, 2021Aug 2, 2021Nov 4, 2021Mar 1, 2022May 10, 2022Aug 8, 2022Nov 10, 2022Feb 28, 2023May 1, 2023Aug 1, 2023Nov 1, 2023Feb 28, 2024May 1, 2024Aug 6, 2024Nov 4, 2024Feb 26, 2025May 5, 2025Aug 4, 2025Nov 3, 2025Feb 26, 2026May 6, 2026Aug 3, 2026Nov 2, 2026
EPS Estimate--------------------------------140.62-112.50-84.37--56.25-28.12-----------------0.06-0.12-0.13-0.11-0.15-0.21-0.17-0.18-0.21-0.32-0.26-0.33-0.33-0.37-0.32-0.34-0.27-0.30-0.36-0.36-0.38-0.40-0.44-0.42-0.50-0.50-0.44-0.44-0.42-0.35-0.46-0.37-0.33-0.44-0.61-0.49-0.50-0.57-0.68-0.59-0.57-0.38-0.26-0.34-0.250.10-0.10-0.04-0.040.030.090.170.290.220.350.280.410.36
EPS Actual-9885.89695.14-5140.91-4030.23-2666.06-1929.43-986.48-2671.02-5766.57-7888.48-2621.34-1374.061855.58-4513.55-1528.45-497.80-552.1024.21-507.41-307.36-91.67-93.46-391.61-225.00-140.65-109.61-240.39-196.87-152.43-934.25-118.85-140.62-112.50-84.37-119.73-196.87-112.50-62.10-56.64-55.535.06-30.34-55.45-16.57-8.88-54.2743.210.969.1884.58-64.63-9.05-2.03-0.16-0.16-0.12-0.18-0.28-0.18-0.19-0.25-0.36-0.36-0.25-0.39-0.38-0.28-0.37-0.28-0.33-0.50-0.48-0.52-0.45-0.48-0.46-0.59-0.59-0.43-0.69-0.43-0.42-0.69-0.44-0.48-0.47-0.73-0.72-0.69-0.59-0.65-0.70-0.51-0.30-0.26-0.39-0.28-0.340.73-0.10-0.070.040.020.150.030.170.160.140.180.05-
Surprise-------------------------------0.00%0.00%0.00%--249.99%-300.07%-----------------166.67%-33.33%7.69%-63.64%-86.67%14.29%-11.76%-38.89%-71.43%-12.50%3.85%-18.18%-15.15%24.32%-15.63%17.65%-22.22%-66.67%-33.33%-44.44%-18.42%-20.00%-4.55%-40.48%-18.00%14.00%-56.82%2.27%0.00%-97.14%4.35%-29.73%-42.42%-65.91%-18.03%-40.82%-18.00%-14.04%-2.94%13.56%47.37%31.58%-50.00%17.65%-36.00%630.00%0.00%-75.00%200.00%-33.33%66.67%-82.35%-41.38%-27.27%-60.00%-35.71%-87.80%-
Timing-----------------------------------------------------After-hoursAfter-hours-After-hoursAfter-hoursAfter-hours-After-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hoursPre-marketPre-marketAfter-hoursAfter-hoursPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketAfter-hoursPre-marketAfter-hoursPre-marketPre-marketPre-marketAfter-hoursAfter-hoursPre-marketAfter-hoursAfter-hoursPre-marketPre-marketPre-marketPre-marketAfter-hoursPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-market-Pre-marketPre-marketPre-market

Key Statistics & Ratios

Market Cap8.79B
Enterprise Value8.75B
Trailing P/E20.96
Forward P/E25.91
PEG Ratio1.61
Price / Sales10.99
Price / Book14.19
EPS2.74
Book Value4.11
Revenue (TTM)799.54M
Gross Profit (TTM)658.60M
EBITDA136.45M
Profit Margin55.22%
Operating Margin9.02%
Return on Equity100.28%
Return on Assets7.28%
Shares Outstanding153.08M
Shares Float135.24M
Beta1.66
Dividend Yield0.00%
Dividend Rate0
Payout Ratio0.00%

Analyst Ratings

Buy
Based on 9 analystsTarget 69.71
  • Strong Buy
    6
  • Buy
    1
  • Hold
    1
  • Sell
    1

Ownership Breakdown

Institutions
74.33%
Insiders
7.47%
Retail / Other
18.20%

Top Institutional Holders

  • BlackRock Inc
    22.25M14.54%
  • State Street Corp
    8.65M5.65%
  • Vanguard Portfolio Management, LLC
    8.27M5.41%
  • Vanguard Capital Management, LLC
    6.60M4.31%
  • Geode Capital Management, LLC
    3.50M2.29%
  • D. E. Shaw & Co LP
    3.40M2.22%
  • ClearBridge Advisors, LLC
    3.21M2.10%
  • Soleus Capital Management, L.P.
    2.93M1.91%
  • Congress Asset Management Company, LLP
    2.60M1.70%
  • Two Sigma Investments LLC
    2.47M1.61%
  • The Goldman Sachs Group Inc
    2.29M1.49%
  • Jane Street Group LLC
    2.04M1.33%
  • Pictet Asset Manangement SA
    1.79M1.17%

Top Fund Holders

  • iShares Core S&P Small-Cap ETF
    8.03M5.25%
  • Vanguard MStar Total Stk Mkt Idx Invest
    4.39M2.87%
  • iShares Russell 2000 ETF
    3.71M2.42%
  • Vanguard Small Cap Index
    3.17M2.07%
  • State Street® SPDR® S&P® Biotech ETF
    2.25M1.47%
  • Vanguard MStar Small Cap Growth Indx Inv
    1.82M1.19%
  • First Trust NYSE Arca Biotech ETF
    1.59M1.04%

Stock Splits

  • Apr 30, 2012100:5625
  • Jul 14, 20111:50